Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 8 studies | 30% ± 10% | |
natural killer cell | 5 studies | 19% ± 3% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 0% | |
myeloid cell | 4 studies | 20% ± 2% | |
macrophage | 4 studies | 33% ± 7% | |
cardiac muscle cell | 3 studies | 21% ± 2% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
dendritic cell | 3 studies | 20% ± 4% | |
monocyte | 3 studies | 21% ± 6% | |
mast cell | 3 studies | 19% ± 1% |
Insufficient scRNA-seq data for expression of GAB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1086.57 | 653 / 653 | 100% | 5.92 | 602 / 605 |
lung | 100% | 1825.75 | 578 / 578 | 92% | 3.93 | 1063 / 1155 |
breast | 100% | 991.58 | 458 / 459 | 91% | 3.10 | 1014 / 1118 |
kidney | 93% | 504.91 | 83 / 89 | 90% | 4.56 | 810 / 901 |
uterus | 99% | 633.69 | 169 / 170 | 73% | 1.97 | 337 / 459 |
adrenal gland | 99% | 574.17 | 256 / 258 | 73% | 1.95 | 169 / 230 |
esophagus | 93% | 650.94 | 1337 / 1445 | 75% | 1.86 | 137 / 183 |
stomach | 89% | 532.81 | 321 / 359 | 77% | 2.36 | 220 / 286 |
intestine | 99% | 907.88 | 961 / 966 | 66% | 1.66 | 347 / 527 |
bladder | 100% | 658.86 | 21 / 21 | 62% | 1.72 | 311 / 504 |
prostate | 97% | 542.42 | 237 / 245 | 60% | 1.18 | 300 / 502 |
skin | 80% | 291.36 | 1439 / 1809 | 74% | 2.76 | 350 / 472 |
pancreas | 64% | 215.95 | 209 / 328 | 89% | 3.78 | 159 / 178 |
brain | 47% | 172.38 | 1232 / 2642 | 98% | 4.82 | 691 / 705 |
ovary | 52% | 218.74 | 93 / 180 | 59% | 1.35 | 254 / 430 |
adipose | 100% | 1353.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.05 | 29 / 29 |
spleen | 100% | 4794.53 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 1923.38 | 860 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 917.56 | 1330 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2175.26 | 892 / 929 | 0% | 0 | 0 / 0 |
liver | 50% | 158.16 | 112 / 226 | 44% | 0.96 | 177 / 406 |
tonsil | 0% | 0 | 0 / 0 | 82% | 3.28 | 37 / 45 |
muscle | 46% | 133.30 | 368 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 31% | 0.62 | 25 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0030225 | Biological process | macrophage differentiation |
GO_0005737 | Cellular component | cytoplasm |
GO_0035591 | Molecular function | signaling adaptor activity |
Gene name | GAB3 |
Protein name | GRB2-associated-binding protein 3 (GRB2-associated binder 3) (Growth factor receptor bound protein 2-associated protein 3) Alternative protein GAB3 GRB2 associated binding protein 3 |
Synonyms | |
Description | |
Accessions | L0R5B0 ENST00000369575.7 [Q8WWW8-1] Q8WWW8 H7C3J9 ENST00000424127.3 [Q8WWW8-2] ENST00000369568.8 [Q8WWW8-3] ENST00000454973.1 |